MetaProteomics
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, MetaProteomics sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
MetaProteomics: 4 sponsored US clinical trials, none currently recruiting.
MetaProteomics sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Obesity, with 1 trials.
Upper-quartile sponsor footprint
MetaProteomics sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Effect of Citrus Bioflavonoids/Vitamin E in Conjunction With Fish Oil Supplementation
NCT01671254
Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects
NCT01656681
Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery
NCT01041261
Trial of Two Dietary Programs on Cardiometabolic Risk Factors in Subjects With Metabolic Syndrome
NCT01010841
Therapeutic Areas
How the MetaProteomics archive is shaped
4 indexed studies, none listed as recruiting (0% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Obesity (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
MetaProteomics: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
MetaProteomics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this MetaProteomics page
4 registered trials is a research-attention snapshot, not an endorsement of MetaProteomics or any single study.
- None of MetaProteomics's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Obesity is the condition MetaProteomics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. MetaProteomics pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.